Oncopharmpod
Zenocutuzumab
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:45
- Mas informaciones
Informações:
Sinopsis
A first-in-class approval of a bispecific HER2-HER3 monoclonal antibody for NRG1 fusion (+) NSCLC and pancreatic cancer.
